Showing 1 - 10 results of 10 for search 'Graefen M', query time: 0.02s
Refine Results
-
1
Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer. by Haese, A, Graefen, M, Huland, H, Lilja, H
Published 2004Journal article -
2
-
3
-
4
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml. by Haese, A, Graefen, M, Steuber, T, Becker, C, Pettersson, K, Piironen, T, Noldus, J, Huland, H, Lilja, H
Published 2001Journal article -
5
Total and gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in ser... by Haese, A, Graefen, M, Steuber, T, Becker, C, Noldus, J, Erbersdobler, A, Huland, E, Huland, H, Lilja, H
Published 2003Journal article -
6
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in ser... by Haese, A, Graefen, M, Steuber, T, Becker, C, Noldus, J, Erbersdobler, A, Huland, E, Huland, H, Lilja, H
Published 2003Journal article -
7
Prediction of tumor heterogeneity in localized prostate cancer. by Huland, H, Graefen, M, Haese, A, Hammerer, P, Palisaar, J, Pichlmeier, U, Henke, R, Erbersdobler, A, Huland, E, Lilja, H
Published 2002Journal article -
8
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue. by Steuber, T, Niemela, P, Haese, A, Pettersson, K, Erbersdobler, A, Felix Chun, K, Graefen, M, Kattan, M, Huland, H, Lilja, H
Published 2005Journal article -
9
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer. by Haese, A, Graefen, M, Becker, C, Noldus, J, Katz, J, Cagiannos, I, Kattan, M, Scardino, P, Huland, E, Huland, H, Lilja, H
Published 2003Journal article -
10
Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer by Kluth M, Volta H, Hussein M, Taskin B, Frogh S, Möller-Koop C, Büscheck F, Jacobsen F, Tsourlakis MC, Lübke AM, Hinsch A, Clauditz T, Graefen M, Heinzer H, Huland H, Minner S, Sauter G, Wilczak W, Schlomm T, Simon R
Published 2018-11-01
Article